Experience of Orthopaedic and Spine Center Pakistan During COVID-19
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04516824 |
Recruitment Status :
Completed
First Posted : August 18, 2020
Last Update Posted : August 18, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
After the frightful outbreak in the city of Wuhan, China and its evidence of being contagious, governments around the world particularly United States in an effort to stop the transmission- imposed travel restrictions to and from China. Though it's a novel virus and little is known about it, the spread was drastic across the world. In fact the spread was so rapid that by end of February 2020, the number of new cases outside China had leveled up to 13 fold as compared to the number of cases in China. Moreover, the number of infected countries with COVID-19 tripled. The first two reported cases in Pakistan were from Karachi and Islamabad on 27 February 2020. These two cases presented with a recent travel history from Iran. The current statistics showed the confirmed cases in Pakistan reached upto 284,121 till 9 August 2020.
During the lockdown period most of the public hospitals and trust closed their Outpatient departments and started to deal with emergency cases only. However even in such situation there are some trust hospitals worth mentioning who never closed their services and worked day and night to entertain their patients by observing all the precautions and safety measures. Ghurki trust teaching hospital is one of them. This hospital adopted a SMART STRATEGY or SMART hospital lockdown.
Since 19th March 2020 till 13th July 2020, the period of lockdown, two thousand one hundred and sixty surgeries were performed by the orthopaedic team of Ghurki hospital. The breakup of surgeries during lockdown was as follows: 1514 cases of trauma, 173 procedures of spine, 51 for arthroplasty, 51 for arthroscopy, 21 for tumors and 350 miscellaneous. The team was available 24 hours, 7 days a week under the supervisor of Professor Amer Aziz, to play their part in these terrible circumstances.
Condition or disease | Intervention/treatment |
---|---|
Orthopaedic Disorders | Procedure: Orthopaedic Surgical Procedures |

Study Type : | Observational |
Actual Enrollment : | 2160 participants |
Observational Model: | Other |
Time Perspective: | Retrospective |
Official Title: | Experience of Workforce From Orthopaedic and Spine Center Ghurki Trust Hospital Pakistan During COVID-19 |
Actual Study Start Date : | March 19, 2020 |
Actual Primary Completion Date : | July 13, 2020 |
Actual Study Completion Date : | August 15, 2020 |

Group/Cohort | Intervention/treatment |
---|---|
Trauma,Spine cases,Arthroplasty,Arthroscopy, Miscellaneous |
Procedure: Orthopaedic Surgical Procedures
Intramedullary nails, Dynamic Compression Plate, Dynamic Hip Screw, Manipulation Under Anaesthesia POP, Ilizarov, Cannulated Screw Fixators, Bipolar Hemiarthroplasty, Locking Compression Plate, AO External fixators, Tension Band Wiring Patella, Pelvis and Acetabulum Fixations, Elbow Reconstructions, K wiring, Disc Excision, Spine Fracture i-e TPSF, Posterior Cervical Decompression and LMS, Dura repair, AD cage,Bilateral Total Hip Replacement, Unilateral Total Hip Replacement, Bilateral Total Knee Replacement, Unilateral Total Knee Replacement, Knee Arthroscopy for Mensicectomy, Arthroscopic Anterior Cruciate Ligament reconstruction,Removal of Implant, Amputations, VAC dressings,Wound wash, Arthrotomy for Septic Arthritis, Biopsy |
- Clinical and functional characteristics [ Time Frame: [Through study period, average 3 months] ]Describe the clinical and functional level of patients after surgery, hospitalized during lockdown period in our hospital
- Patient's journey [ Time Frame: [Through study period, average 3 months] ]Describe patient's experience during the period of lockdown in our center

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients indicated for surgical procedure
- Less affording patients coming from remote areas with the need of immediate orthopaedic surgery
- Urgent elective and emergency procedures
Exclusion Criteria:
- Elective surgery cases which were not urgent
- Patients in whom conservative management could be considered.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04516824
Pakistan | |
Ghurki trust hospital | |
Lahore, Punjab, Pakistan, 54000 |
Study Director: | Prof Amer Aziz | Orthopaedic and Spine Center Ghurki Trust Hospital Lahore Pakistan | |
Study Chair: | Prof. Atiq Uz Zaman | Orthopaedic and Spine Center Ghurki Trust Hospital Lahore Pakistan | |
Study Chair: | Prof Rizwan Akram | Orthopaedic and Spine Center Ghurki Trust Hospital Lahore Pakistan | |
Study Chair: | Prof. Ijaz Ahmad | Orthopaedic and Spine Center Ghurki Trust Hospital Lahore Pakistan | |
Study Chair: | Dr. Ashfaq Jadoon | Orthopaedic and Spine Center Ghurki Trust Hospital Lahore Pakistan | |
Study Chair: | Dr. Majid Cheema | Orthopaedic and Spine Center Ghurki Trust Hospital Lahore Pakistan | |
Study Chair: | Dr. Samreen Sadiq | Lahore College of Physical Therapy LMDC GTTH |
Responsible Party: | Ghurki Trust and Teaching Hospital |
ClinicalTrials.gov Identifier: | NCT04516824 |
Other Study ID Numbers: |
30 |
First Posted: | August 18, 2020 Key Record Dates |
Last Update Posted: | August 18, 2020 |
Last Verified: | August 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
COVID 19 Orthopaedic conditions Orthopaedic Surgeries Pakistan |